Actively Recruiting
Effect of Hilotherapy in the Management of Symptoms Related to Taxane-Associated Peripheral Neuropathy
Led by Nuran Ayşen Pamir Aksoy · Updated on 2026-01-15
60
Participants Needed
2
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this randomized controlled study, it was aimed to determine the effect of hilotherapy on quality of life and comfort level in the management of symptoms related to taxane-associated peripheral neuropathy in patients with breast cancer. * The experimental and control group patients will answer the survey questions according to the data collection forms before the first chemotherapy course (To) and will undergo physical examinations by the researcher. * In the experimental group, the Hilotherapy device will be connected and initiated 30 min before the chemotherap. * The device will continue to cool for another 60 minutes when the chemotherapy ends. * Both groups will continue to receive chemotherapy courses at the intervals determined as planned. * Hilotherapy will be applied to the experimental group patients during each course according to the study protocol. * For both groups, participants will answer the questions according to the data collection forms and will undergo physical examinations by the researcher after the 4th chemotherapy course (T1), 8th chemotherapy course (T2), 12th chemotherapy course (T3) and 4 weeks after the end of chemotherapy (T4).
CONDITIONS
Official Title
Effect of Hilotherapy in the Management of Symptoms Related to Taxane-Associated Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with primary breast cancer
- Receiving chemotherapy containing taxane compounds for breast cancer
- No previous diagnosis of peripheral neuropathy
You will not qualify if you...
- Presence of distant metastasis
- History of psychiatric disorder
- Diagnosed with diabetes mellitus, autoimmune disease, megaloblastic anemia, cervical or spinal disc herniation, or Raynaud's phenomenon
- Active wounds or lesions on hands or feet
- Bleeding or clotting disorder
- Amputation of limbs
- Any condition preventing cognitive, emotional, or verbal communication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Acibadem Altunizade Hospital
Istanbul, Turkey (Türkiye)
Actively Recruiting
2
Acibadem Maslak Hospital
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
N
Nermin Ocaktan, Assist. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here